Evidence map›Paper›PMID 42751170›Full record

ReviewFrontiers in public health2026

Integrating digital therapeutics for patients with mental illness into clinical practice: perspectives for US healthcare professionals.

Brandon M Kitay, David C Mohr, Stephen M Schueller

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brandon M Kitay *Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, GA, United States.
David C Mohr *Department of Preventive Medicine, Center for Behavioral Intervention Technologies, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Stephen M Schueller *Department of Psychology, University of California Irvine, Irvine, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the landscape of digital health tools has expanded, digital therapeutics have emerged as promising treatment options for various mental health conditions. Although digital therapeutics have demonstrated efficacy in prevention, treatment, and management of mental illness, adoption of these interventions in clinical practice remains low. Here, key questions for healthcare providers about implementation of digital therapeutics into US clinical practice are addressed, focusing on digital therapeutics for mental illness. The landscape of digital therapeutics is described and current barriers to adoption across stakeholders are discussed, considering patients, providers, and health systems. This article further highlights opportunities for development and population-based implementation of digital therapeutics.

Indexed as

Health PersonnelMental DisordersTelemedicineDigital HealthDigital MediaHumansUnited Statesclinical practiceclinician perspectivesdigital therapeuticsimplementation sciencemental health

Identifiers

PMID42751170
PMCPMC13579911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.